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Abstract 
Purpose: To synthesize a series of new N-(2,3-dimethylphenyl)benzenesulfonamide derivatives with 
pharmacological analysis.  
Methods: N-(2,3-Dimethylphenyl)benzenesulfonamide (3) was synthesized by the reaction between 
2,3-dimethylaniline (1) and benzenesulfonyl chloride (2) in aqueous basic medium. Compound 3 was 
further treated with various alkyl/aralakyl halides (4a-m) to yield new compounds, 5a-m, in a weak basic 
aprotic polar organic medium. The proposed structures of synthesized compounds were confirmed 
using proton-nuclear magnetic resonance (1H-NMR), infra-red spectroscopy (IR) and electron impact 
mass spectrometry (EIMS). The synthesized compounds were screened for in vitro antibacterial, anti-
enzymatic and hemolytic activities using standard procedures. 
Results: All the synthesized compounds showed moderate to high activity against Gram-positive and 
Gram-negative bacterial strains. The molecules 5g and 5j exhibited good inhibition of α-glucosidase 
enzyme with half-maximal inhibitory concentration (IC50) of 59.53 ± 0.01 and 55.31 ± 0.01 μmoles/L, 
respectively, relative to acarbose with IC50 of 38.25 ± 0.12 μmoles/L. All the compounds exhibited 
cytotoxicity levels ranging from 27.20 ± 0.24 to 5.20 ± 0.41 %, relative to Triton X-100. 
Conclusion: Compound 5f is the most potent antibacterial while 5j is the best α-glucosidase inhibitor; 
5e showed the least cytotoxicity. 
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Sulfonamides exhibit numerous pharmacological 
activities [1-3] and sulfonamide antibiotics are 
among the most common instigators of allergic or 
hypersensitivity reactions [4-6]. α-Glucosidase 
(α-D-glucosideglucohydrolase, EC 
3.2.1.20)hydrolyzes the 1,4-glycosidic linkage 
from the non-reducing end of the α-glucosides 
[7-9].Its inhibitors retard the liberation of D-
glucose resulting in delay glucose absorption 
[10]. The hemolysis takes place due to the stroke 
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of the microbial products and resident parasites 
on the red blood corpuscles membranes [11,12]. 
Our group has synthesized many antibacterial 
and anti-enzymatic potent molecules [13-16] and 
a series of new compounds was synthesized in 
the present study to explore their 






The chemicals solvents were of commercial 
grade and were used without purification. 
Reaction progress and product purity was 
monitored by pre-coated TLC silica gel G-25-
UV254 plates with different solvent systems 
using ethyl acetate and n-hexane. Melting points 
were noted on Gallenkamp apparatus by open 
capillary tube and were uncorrected. FTIR 
spectra were recorded on MIDAC M 2000 
spectrometer. 1H-NMR spectra were recorded in 
CDCl3 on Bruker (400 MHz). Mass spectra (EI-
MS) were measured on Finnigan MAT-312 
instruments. 
 
Procedure for the synthesis of N-(2,3-
dimethylphenyl)benzenesulfonamide (3) 
 
An equimolar mixture of 2,3-dimethylaniline (1, 
0.02 mol) was dispersed in 25 mL waterfollowed 
by the addition ofbenzenesulfonyl chloride (2, 
0.02 mol). The pH of the suspension was 
maintained at 9-10 during the whole reaction by 
adding Na2CO3 at RT. The reaction solution was 
stirred for 3 h. After complete reaction, the 
concentrated HCl (2-3 mL) was added slowly to 
adjust the pH to 2. Product formation was 
confirmed by TLC. The reaction mixture was kept 
still for 3-5 min. The off-white precipitates were 
collected by filtration, washed with distilled water 
and dried to acquire the compound 3.  
 
General procedure for the synthesis of N-
alkyl/aralakyl substituted sulfonamides (5a-
m) 
 
The calculated amount of 3 (0.7 mmol; 0.2 g) 
was taken in a round bottom flask (50 mL), then 
N,N-dimethyl formamide (DMF) was added to 
dissolve it followed by the addition of lithium 
hydride LiH (0.004 g). The mixture was stirred for 
45 min at RT and then alkyl/aralakyl halides (4a-
m; 0.7 mmol) were added to the mixture. The 
solution was further stirred for 3-4 h. The 
progress of reaction was monitored by TLC. The 
product was precipitated by adding cold water, 
filtered, washed with distilled water and dried. 
 
 
Evaluation of antibacterial activity 
 
The antibacterial activity was performed in sterile 
96-wells microplates under aseptic environments 
by the methods of Kaspady et al [17] and Yang 




The α-glucosidase inhibition activity was 
performed according to the method of 
Chapdilaine et al [10]. 
 
Determination of hemolytic activity 
 
Hemolytic activity was studied by the reported 
method of Powell et al [11,19]. 3.0 mL fresh 
heparin added human blood obtained from 
volunteers after guidance from the Department of 
Clinical Medicine and Surgery, University of 
Agriculture, Faisalabad, Pakistan. The study 
protocol was approved by the institutional ethical 
committee (approval no. DGS/8786-89, dated 
09-03-2015), University of Agriculture, 
Faisalabad, Pakistan and was conducted in 
accordance with 1964 Declaration of Helsinki 




All the measurements were performed in 
triplicate and statistical analysis was carried out 
by Microsoft Excel 2010. The results are 
presented as mean ± SEM with CL 80 % (for 
antibacterial), 85 % (for α-glucosidase) and 95 % 
(for hemolytic analysis). MIC (minimum inhibitory 
concentration and IC50 (50 % inhibitory 
concentration) were calculated using EZ-Fitz 




The new N-substituted derivatives of N-(2,3-
dimethylphenyl)benzenesulfonamide were 
synthesized according to the protocol sketched in 
Scheme-1.  
 
The antibacterial activities are given in Table-1 
while inhibition against α-glucosidase enzyme 
and hemolytic activity are tabulated in Table 2. 
 
Spectral characteristics of synthesized 





Yield: 98 %; off-white solid; mp. 118-119 °C; 
Molecular formula: C14H15NO2S; Molecular 
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Scheme-1: N-alkyl/aralakyl substituted derivatives of 3 
 
weight: 261; Analysis. Calcd: C, 64.32; H, 5.74; 
N, 5.36; S, 12.25. Found: C, 64.03; H, 6.40; N, 
5.52; S, 11.73;IR (cm-1) υmax:3208(N-H), 3042 (Ar 
C-H), 2924(Alkane C-H), 1583(Ar C=C), 1324 
(S=O); 1H-NMR (400 MHz, CDCl3, δ in ppm): 
7.69 (2H, d, J = 7.6Hz, H-2', H-6'), 7.53 (1H, t, J 
= 7.6 Hz, H-4'), 7.41 (2H, t, J = 7.6 Hz, H-3', H-
5'), 7.13 (1H, d, J = 7.6Hz, H-6), 6.96 (1H, t, J = 
7.6Hz, H-5), 6.46 (1H, d, J = 8.4Hz, H-4), 2.18 
(3H, s, CH3-2), 1.91 (3H, s, CH3-3); EI-MS (m/z): 






Yield: 99 %; light mustard solid; mp. 85.8 °C; 
Molecular formula: C16H19NO2S; Molecular 
weight: 289; Analysis. Calcd: C, 66.43; H, 6.56; 
N, 4.84; S, 11.07. Found: C, 64.90; H, 6.29; N, 
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4.52; S, 11.02;IR (cm-1) υmax:3065 (Ar C-H), 2934 
(Alkane C-H), 1583 (Ar C=C), 1341 (S=O); 1H-
NMR (400 MHz, CDCl3, δ in ppm): 7.67 (2H, d, J 
= 7.6Hz, H-2', H-6'), 7.55 (1H, t, J = 7.6Hz, H-4'), 
7.46 (2H, t, J = 7.6Hz, H-3', H-5'), 7.08 (1H, d, J 
= 7.6Hz, H-6), 6.92 (1H, t, J = 7.6Hz, H-5), 6.39 
(1H, d, J = 8.0Hz, 1H, H-4), 3.86-3.77 (1H, m, 
Ha-1''), 3.31-3.23 (1H, m, Hb-1''), 2.28 (3H, s, 
CH3-2), 2.26 (3H, s, CH3-3), 1.02 (3H, t, J = 
7.2Hz, CH3-2''); EI-MS (m/z): 289 (M+, 9.3%), 





Yield: 99 %; light pink solid; mp. 79 °C; Molecular 
formula: C17H21NO2S; Molecular weight: 303; 
Analysis. Calcd: C, 67.32; H, 6.93; N, 4.62; S, 
10.56. Found: C, 66.35; H, 6.70; N, 4.61; S, 
10.57; IR (cm-1) υmax:3071 (Ar C-H), 2978 
(Alkane C-H), 1586 (Ar C=C), 1336 (S=O); 1H-
NMR (400 MHz, CDCl3, δ in ppm): 7.66 (2H, d, J 
= 7.2Hz, H-2', H-6'), 7.56 (1H, t, J = 7.6Hz, H-4'), 
7.46 (2H, t, J = 7.6Hz, 2H, H-3', H-5'), 7.08 (1H, 
d, J = 7.6Hz, H-6), 6.91 (1H, t, J = 7.6Hz, H-5), 
6.89 (1H, d, J = 8.0Hz, H-4), 3.69-3.62 (1H, m, 
Ha-1''), 3.18-3.12 (1H, m, Hb-1''), 2.27 (3H, s, 
CH3-2), 2.25 (3H, s, CH3-3), 1.53-1.33 (2H, m, H-
2''), 0.83 (3H, t, J = 7.2Hz, CH3-3''); EI-MS (m/z): 






Yield: 53 %; light pink solid; mp. 103.1 °C; 
Molecular formula: C17H21NO2S; Molecular 
weight: 303; Analysis. Calcd: C, 67.32; H, 6.93; 
N, 4.62; S, 10.56. Found: C, 66.56; H, 6.69; N, 
4.37; S, 10.70; IR (cm-1) υmax:3066 (Ar C-H), 
2977 (Alkane C-H), 1584 (Ar C=C), 1335 (S=O); 
1H-NMR (400 MHz, CDCl3, δ in ppm): 7.72 (2H, 
d, J = 7.6Hz, H-2', H-6'), 7.53 (1H, t, J = 7.6Hz, 
H-4'), 7.44 (2H, t, J = 7.2Hz, H-3', H-5'), 7.13 
(1H, d, J = 7.6Hz, H-6), 6.96 (1H, t, J = 7.6Hz, H-
5), 6.56 (1H, d, J = 7.9Hz, H-4), 4.63-4.56 (1H, 
m, H-1''), 2.28 (3H, s, CH3-2), 2.23 (3H, s, CH3-
3), 1.02 (3H, d, J = 6.4Hz, CH3-2''), 0.92 (3H, d, J 
= 6.4Hz, CH3-3''); EI-MS (m/z): 303 (M+, 33.4%), 





Yield: 98 %; light pink solid; mp. 54.7 °C; 
Molecular formula: C18H23NO2S; Molecular 
weight: 317; Analysis. Calcd: C, 68.13; H, 7.25; 
N, 4.41; S, 10.09. Found: C, 66.91; H, 6.87; N, 
4.09; S, 10.18; IR (cm-1) υmax:3070 (Ar C-H), 
2955 (Alkane C-H), 1583 (Ar C=C), 1335 (S=O); 
1H-NMR (400 MHz, CDCl3, δ in ppm): 7.65 (2H, 
d, J = 7.2Hz, 2H, H-2', H-6'), 7.56 (1H, t, J = 
7.6Hz, H-4'), 7.45 (2H, t, J = 7.6Hz, H-3', H-5'), 
7.08 (1H, d, J = 7.2Hz, H-6), 6.91 (1H, t, J = 
7.6Hz, H-5), 6.39 (1H, d, J = 8.0Hz, H-4), 3.74-
3.67 (1H, m, Ha-1''), 3.20-3.13 (1H, m, Hb-1''), 
2.28 (3H, s, CH3-2), 2.25 (3H, s, CH3-3), 1.52-
1.41 (2H, m, H-2''), 1.30-1.26 (2H, m, H-3''), 0.92 
(3H, t, J = 7.2Hz, CH3-4''); EI-MS (m/z): 317 (M+, 





Yield: 41 %; pinkish white solid; m.p. 92.6 °C; 
Molecular formula: C18H23NO2S; Molecular 
weight: 317; Analysis. Calcd: C, 68.13; H, 7.25; 
N, 4.41; S, 10.09. Found: C, 66.65; H, 6.88; N, 
4.64; S, 10.34;IR (cm-1) υmax: 3062 (Ar C-H), 
2973 (Alkane C-H), 1585 (Ar C=C), 1337 (S=O); 
1H-NMR (400 MHz, CDCl3, δ in ppm): 7.71 (2H, 
d, J = 7.6Hz, H-2', H-6'), 7.53 (1H, t, J = 7.2Hz, 
H-4'), 7.44 (2H, t, J = 7.6Hz, H-3', H-5'), 7.12 
(1H, d, J = 7.2Hz, H-6), 6.95 (1H, t, J = 7.6Hz, H-
5), 6.54 (1H, d, J = 8.0Hz, H-4), 4.29-4.23 (1H, 
m, H-1''), 2.26 (3H, s, CH3-2), 2.23 (3H, s, CH3-
3), 1.01 (3H, d, J = 6.8 Hz,H-4''), 0.90-0.85 (2H, 
m, H-2''), 0.74 (3H, t, J = 7.2Hz, CH3-3''); EI-MS 
(m/z): 317 (M+, 16.7%),147 (BP, 100%), 141, 





Yield: 93 %; pinkish white solid; mp. 72.3 °C; 
Molecular formula: C19H25NO2S; Molecular 
weight: 331; Analysis. Calcd: C, 68.88; H, 7.55; 
N, 4.22; S, 9.66. Found: C, 68.26; H, 7.16; N, 
4.52; S, 9.95;IR (cm-1) υmax: 3069 (Ar C-H), 2959 
(Alkane C-H), 1585(Ar C=C), 1332 (S=O); 1H-
NMR (400 MHz, CDCl3, δ in ppm): 7.65 (2H, d, J 
= 7.2Hz, H-2', H-6'), 7.55 (1H, t, J = 7.6Hz, H-4'), 
7.45 (2H, t, J = 7.2Hz, H-3', H-5'), 7.08 (1H, d, J 
= 7.2Hz, H-6), 6.91 (1H, t, J = 7.6Hz, H-5), 6.39 
(1H, d, J = 8.0Hz, H-4), 3.73-3.65 (1H, m, Ha-1''), 
3.20-3.13 (1H, m, Hb-1''), 2.28 (3H, s, CH3-2), 
2.25 (3H, s, CH3-3), 1.51-1.45 (2H, m, H-2''), 
1.26-1.20 (4H, m, H-3'', H-4'' ), 0.81 (3H, t, J = 
6.8Hz, CH3-5''); EI-MS (m/z): 331 (M+, 34.1%), 





Yield: 89 %; light brownish liquid (extracted with 
chloroform); Molecular formula: C19H25NO2S; 
Molecular weight: 331; Analysis. Calcd: C, 68.88; 
H, 7.55; N, 4.22; S, 9.66. Found: C, 68.23; H, 
7.46; N, 4.19; S, 8.92;IR (cm-1) υmax: 3070 (Ar C-
H), 2936 (Alkane C-H), 1580 (Ar C=C), 1341 
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(S=O); 1H-NMR (400 MHz, CDCl3, δ in ppm): 
7.71 (2H, d, J = 7.6Hz, H-2', H-6'), 7.53 (1H, t, J 
= 7.2Hz, H-4'), 7.44 (2H, t, J = 7.6Hz, H-3', H-5'), 
7.12 (1H, d, J = 7.2Hz, H-6), 6.95 (1H, t, J = 
7.6Hz, H-5), 6.64 (1H, d, J = 7.6Hz, H-4), 4.36-
4.33 (1H, m, H-1''), 1.32-1.23 (2H, m, H-2''), 
1.15-1.12 (2H, m, H-3''), 1.01 (3H, d, J = 6.8Hz, 
CH3-5''), 0.77 (3H, t, J = 7.2Hz, CH3-4''); EI-MS 
(m/z): 331 (M+, 1.1%), 141, 120, 105, 77 (BP, 





Yield: 88 %; shiny pinkish white solid; mp. 80.8 
°C; Molecular formula: C21H21NO2S; Molecular 
weight: 351; Analysis. Calcd: C, 71.79; H, 5.98; 
N, 3.98; S, 9.11. Found: C, 70.32; H, 5.72; N, 
3.66; S, 9.26;IR (cm-1) υmax: 3054 (Ar C-H), 2927 
(Alkane C-H), 1585 (Ar C=C), 1330 (S=O); 1H-
NMR (400 MHz, CDCl3, δ in ppm): 7.71 (2H, d, J 
= 7.6Hz, H-2', H-6'), 7.59 (1H, t, J = 7.6Hz, H-4'), 
7.48 (2H, t, J = 7.2Hz, H-3', H-5'), 7.18-7.09 (5H, 
m, H-2'' to H-6''), 7.01 (1H, d, J = 7.6Hz, H-6), 
6.88 (1H, t, J = 7.6, H-5), 6.41 (1H, d, J = 8.0Hz, 
H-4), 4.96 (1H, d, J = 13.6 Hz, Ha-7''), 4.24 (1H, 
d, J = 13.6 Hz, Hb-7''), 2.14 (3H, s, CH3-2), 1.88 
(3H, s, CH3-3); EI-MS (m/z): 351 (M+, 13.4%), 





Yield: 98 %; pinkish white solid; mp. 109 °C; 
Molecular formula: C21H20ClNO2S; Molecular 
weight: 385; Analysis. Calcd: C, 65.45; H, 5.19; 
N, 3.63; S, 8.31. Found: C, 65.01; H, 5.38; N, 
3.80; S, 7.71;IR (cm-1) υmax: 3063 (Ar C-H), 2927 
(Alkane C-H), 1582 (Ar C=C), 1342 (S=O), 576 
(C-Cl); 1H-NMR (400 MHz, CDCl3, δ in ppm): 
7.72 (2H, d, J = 7.6Hz, H-2', H-6'), 7.60 (1H, t, J 
= 7.6Hz, H-4'), 7.49 (2H, t, J = 7.6Hz, H-3', H-5'), 
7.33 (1H, dd, J = 7.2, 3.2 Hz, H-3''), 7.19 (1H, dd, 
J = 6.4, 2.8Hz, H-6''), 7.13-7.09 (2H, m, H-4'', H-
5''), 7.00 (1H, d, J = 7.6 Hz, H-6), 6.87 (1H, t, J = 
7.6 Hz, H-5), 6.52 (1H, d, J = 7.6Hz, H-4), 5.08 
(1H, d, J = 14.0 Hz, Ha-7''), 4.53 (1H, d, J = 14.0 
Hz, Hb-7''), 2.13 (3H, s, CH3-2), 1.91 (3H, s, CH3-
3); EI-MS (m/z): 387 ([M+2]+, 6.1%), 385 (M+, 






Yield: 50 %; pinkish white solid; mp. 104.8 °C; 
Molecular formula: C21H20ClNO2S; Molecular 
weight: 385; Analysis. Calcd for: C, 65.45; H, 
5.19; N, 3.63; S, 8.31. Found: C, 64.86; H, 5.45; 
N, 3.35; S, 8.18; IR (cm-1) υmax:3066 (Ar C-H), 
2923 (Alkane C-H), 1584 (Ar C=C), 1342 (S=O), 
581 (C-Cl); 1H-NMR (400 MHz, CDCl3, δ in ppm): 
7.69 (2H, d, J = 7.6Hz, H-2', H-6'), 7.59 (1H, t, J 
= 7.2Hz, H-4'), 7.48 (2H, t, J = 7.6Hz, H-3', H-5'), 
7.15 (2H, d, J = 8.4 Hz, H-3'', H-5''), 7.05 (2H, d, 
J = 8.4Hz, H-2'', H-6''), 7.02 (1H, d, J = 8.0 Hz, 
H-6), 6.88 (1H, t, J = 7.6 Hz, H-5), 6.39 (1H, d, J 
= 7.6Hz, H-4), 4.91 (1H, d, J = 13.6 Hz, Ha-7''), 
4.21 (1H, d, J = 13.6 Hz, Hb-7''), 2.15 (3H, s, 
CH3-2), 1.89 (3H, s, CH3-3); EI-MS (m/z): 387 
([M+2]+, 5.2%), 385 (M+, 15.4%), 141, 120, 125 





Yield: 98 %; off-white solid; mp. 106.3 °C; 
Molecular formula: C21H20BrNO2S; Molecular 
weight: 430; Analysis. Calcd: C, 58.60; H, 4.65; 
N, 3.25; S, 7.44. Found: C, 58.19; H, 4.72; N, 
3.41; S, 7.12;IR (cm-1) υmax:3065 (Ar C-H), 2924 
(Alkane C-H), 1586 (Ar C=C), 1342 (S=O), 585 
(C-Br); 1H-NMR (400 MHz, CDCl3, δ inppm): 7.69 
(2H, d, J = 7.2Hz, H-2', H-6'), 7.59 (1H, t, J = 
7.6Hz, H-4'), 7.48 (2H, t, J = 7.6Hz, H-3', H-5'), 
7.30 (2H, d, J = 8.4 Hz, H-3'', H-5''), 7.02 (1H, d, 
J = 8.0 Hz, H-6), 6.99 (2H, d, J = 8.4Hz, H-2'', H-
6''), 6.88 (1H, t, J = 7.6 Hz, H-5), 6.39 (1H, d, J = 
8.0Hz, H-4), 4.89 (1H, d, J = 13.6 Hz, Ha-7''), 
4.20 (1H, d, J = 14.0 Hz, Hb-7''), 2.16 (3H, s, 
CH3-2), 1.90 (3H, s, CH3-3); EI-MS (m/z): 432 
([M+2]+, 7.8%), 430 (M+, 8.2%), 141, 120, 169, 





Yield: 89 %; pinkish white solid; mp. 103.5 °C; 
Molecular formula: C22H23NO2S; Molecular 
weight: 365; Analysis. Calcd for: C, 72.32; H, 
6.30; N, 3.83; S, 8.76. Found: C, 71.71; H, 6.12; 
N, 3.95; S, 8.90; IR (cm-1) υmax:3064 (Ar C-H), 
2922 (Alkane C-H), 1582 (Ar C=C), 1342 (S=O); 
1H-NMR (400 MHz, CDCl3, δ inppm): 7.64 (2H, d, 
J = 8.0Hz, H-2', H-6'), 7.54 (1H, t, J = 7.2Hz, H-
4'), 7.44 (2H, t, J = 8.0Hz, H-3', H-5'), 7.22 (2H, 
d, J = 7.6 Hz, H-3'', H-5''), 7.17 (1H, t, J = 6.8 Hz, 
H-4''), 7.11 (1H, d, J = 7.2 Hz, H-6), 7.06 (2H, d, 
J = 7.2Hz, H-2'', H-6''), 6.95 (1H, t, J = 7.6 Hz, H-
5), 6.47 (1H, d, J = 8.0Hz, H-4), 4.00-3.93 (1H, 
m, Ha-8''), 3.46-3.36 (1H, m, Hb-8''), 2.88-2.82 
(1H, m, Ha-7''), 2.68-2.62 (1H, m, Hb-7''), 2.29 
(3H, s, CH3-2), 2.21 (3H, s, CH3-3); EI-MS (m/z): 
365 (M+, 25.8%), 141, 120, 105, 104, 77 (BP, 
100%), 51. 
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Yield: 88 %; brownish white solid; mp. 60.5 °C; 
Molecular formula: C17H19NO2S; Molecular 
weight: 301; Analysis. Calcd: C, 67.77; H, 6.31; 
N, 4.65; S, 10.63. Found: C, 66.83; H, 6.08; N, 
4.30; S, 10.72;IR (cm-1) υmax: 3063(Ar C-H), 2946 
(Alkane C-H), 1580 (Ar C=C), 1705 (Alkene 
C=C), 1341 (S=O); 1H-NMR (400 MHz, CDCl3, δ 
in ppm): 7.68 (2H, d, J = 7.6Hz, H-2', H-6'), 7.56 
(1H, t, J = 7.2Hz, H-4'), 7.47 (2H, t, J = 7.6Hz, H-
3', H-5'), 7.07 (1H, d, J = 7.6 Hz, H-6), 6.90 (1H, 
t, J = 7.6 Hz, H-5), 6.39 (1H, d, J = 7.6Hz, H-4), 
5.76-5.69 (1H, m, H-2''), 4.97 (1H, dd, J = 6.4, 
2.8 Hz, Hb-3''), 4.30 (1H, dd, J = 7.6, 2.8 Hz, Ha-
3''), 3.87 (2H, d, J = 6.4 Hz, H-1''), 2.26 (3H, s, 
CH3-2), 2.23 (3H, s, CH3-3); EI-MS (m/z): 301 




The synthesized compounds were evaluated 
against two Gram-positive and four Gram-
negative bacterial strains using ampicillin and 
ciprofloxacin as standards. (Table 1). The 
compounds showed moderate to significant 
activity against bacterial strains except 
compounds, 5a, 5d and 5e. The compound 3 
was active against one strain of gram-positive 
bacteria only. The preliminary screening showed 
that compound, 5c, 5f, 5g, 5i, 5l and 5m were 
the most active ones against gram-positive and 
compounds, 5b, 5f, 5j and 5k were more active 




The screening against α-glucosidase enzyme 
demonstrated that the most of compounds were 
active with good inhibitory potential except 5a, 
5b, 5c and 3 (Table-2). The molecules 5g and 5j 
were found to be excellent inhibitors with their 
IC50 values of 59.53 ± 0.008 and 55.31 ± 0.01 
μmoles/L respectively, relative to acarbose a 





The compounds 5a, 5b, 5d, 5h and 5j exhibited 
cytotoxic activity with percent lysis of 27.2 ± 0.24, 
22.4 ± 0.21, 21.7 ± 0.68, 18.2 ± 0.56 and 18.9 ± 
0.23 respectively, which was much lower than 
the positive control triton X-100 (0.1 % v/v) which 
has percent lysis value of 100.The compound 5e 
was the least cytotoxic in this series with percent 




Sulfonamide 3 was obtained as off-white powder. 
Although its structure has been established by 
the x-ray crystallography [21] but more structural 
details are presented here for the first time. Its 
molecular formula, C14H15NO2S, was determined 
through CHNS analysis with percentage of 
elements as C: 64.03 %; H: 6.40 %; N: 5.52 % 
and S: 11.73 %.  
 
Table 1: MIC of synthesized compounds  
 
Compound MIC B. subtilis (+) S. aureus (+) E. coli (-) S. sonnei (-) S. typhi (-) P. aeruginosa (-) 
3 16.11±0.19 - - - - - 
5a - - - - - - 
5b 11.46±0.22 - 12.11±0.27 19.83±0.04 16.56±0.31 11.7 ±0.32 
5c 14.28±0.24 11.36 ±0.20 16.23±0.14 - 13.01±0.18 11.06±0.70 
5d - - - - - - 
5e - - - - - - 
5f 17.40±0.28 12.51 ±0.31 11.36±0.00 15.04±0.33 13.17±0.18 13.34±0.12 
5g 18.52±0.00 19.33 ±0.32 16.13±0.57 12.62±0.19 - - 
5h - 15.52 ±0.09 19.00±0.18 - 16.33±0.28 14.40±1.23 
5i 10.78±0.09 13.47 ±0.52 18.86±0.01 - - 12.20±0.31 
5j 12.52±0.73 - 17.36±0.18 11.86±0.12 12.33±0.15 13.22±0.50 
5k - 10.78 ±0.46 16.54±0.38 16.43±0.21 10.89±0.11 13.98±0.90 
5l 17.43±0.24 12.52 ±0.11 15.36±0.28 18.09±0.83 - 14.52±0.24 
5m 10.10±0.29 17.43 ±0.13 - - - 14.55±0.02 
Ampicillin 13.92±0.29 11±0.01 11.32±0.13 13.11±0.11 12.78±0.21 16.86±0.31 
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The molecular formula was also supported by 
EI–MS, showing a [M]+ ion peak at m/z 261 and 
by the integration curves in its 1H-NMR spectrum 
indicating the number of protons for each peak. 
The signals in 1H-NMR spectrum, appearing at δ 
7.69 (d, J = 7.6Hz, 2H, H-2', H-6'), 7.53 (t, J = 7.6 
Hz, 1H, H-4') and 7.41 (t, J = 7.6 Hz, 2H, H-3', H-
5') were typical for the protons of the 
benzenesulfonyl group present in the molecule. 
Furthermore, the signals resonating at δ 7.13 (d, 
J = 7.6Hz, 1H, H-6), 6.96 (t, J = 7.6Hz, 1H, H-5), 
6.46 (d, J = 6.39Hz, 1H, H-4), 2.18 (s, 3H, CH3-
2) and 1.91 (s, 3H, CH3-3) were assigned to the 
protons of substituted aniline ring. FT-IR 
supported the structure by absorption bands at 
3208 (N-H), 3042 (Ar C-H), 2924 (Alkane C-H), 
1583 (Ar C=C) and 1324 (S=O) cm-1. On the 
basis of above accumulative manifests, the 
structure of 3 was confirmed as N-(2,3-
dimethylphenyl)benzenesulfonamide. Similarly, 
the structures of other compounds, 5a-m, were 
characterized.  
 
The antibacterial activity results declared the 
compound 5f bearing aliphatic straight chain with 
moderate length at nitrogen atom was the most 
active molecule against all the bacterial strains 
used in this study. The compounds with 
sulfamoyl moiety have been introduced as 
valuable biologically active compounds and in 
accordance with our previous findings [13-16], 
the overview of synthesized compounds hereby 
showed that N-substitution of sulfamoyl group 
with aliphatic chains and halogenated aromatic 
compounds presented best activity because of 
best fit to active site of enzyme and better π-π 
interactions. The two molecules, 5g and 5j, 
showed good activity against α-glucosidase 
probably because of branched long alkyl chain in 
5g and p-substituted halogenated aralkyl group 
in 5j, presented better binding interactions with 
the active site of enzyme. The compound 5e was 
the least cytotoxic in this series but it was 
inferred that all the compounds can be used as 




All the compounds have been structurally 
identified by spectral data and screened for 
antibacterial, α-glucosidase and hemolytic 
analysis. The synthesized compounds exhibit 
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